Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-α and not by Fas ligand

被引:107
作者
Josephs, MD
Bahjat, FR
Fukuzuka, K
Ksontini, R
Solorzano, CC
Edwards, CK
Tannahill, CL
MacKay, SLD
Copeland, EM
Moldawer, LL [1 ]
机构
[1] Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA
[2] Amgen, Thousand Oaks, CA 91320 USA
关键词
apoptosis; hepatitis; sepsis; shock;
D O I
10.1152/ajpregu.2000.278.5.R1196
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Tumor necrosis factor (TNF)-alpha and Fas ligand (FasL) are trimeric proteins that induce apoptosis through similar caspase-dependent pathways. Hepatocytes are particularly sensitive to inflammation-induced programmed cell death, although the contribution of TNF-alpha and/or Fast to this injury response is still unclear. Here, we report that D-galactosamine and lipopolysaccharide-induced liver injury in C57BL/6 mice is associated with increased hepatic expression of both TNF-alpha and Fast mRNA. Pretreatment of mice with a TNF-binding protein improved survival, reduced plasma aspartate aminotransferase concentrations, and attenuated the apoptotic liver injury, as determined histologically and by in situ 3' OH end labeling of fragmented nuclear DNA. In contrast, pretreatment of mice with a murine-soluble Fas fusion protein (Fasfp) had only minimal effect on survival, and apoptotic liver injury was either unaffected or exacerbated depending on the dose of Fasfp employed. Similarly, mice with a spontaneous mutation in Fast (B6Smn.C3H-Fasl(gld) derived from C57BL/6) were equally sensitive to D-galactosamine/lipopolysaccharide-induced shock. We conclude that the shock and apoptotic liver injury after D-galactosamine/lipopolysaccharide treatment are due primarily to TNF-alpha release, whereas increased Fast expression appears to contribute little to the mortality and hepatic injury.
引用
收藏
页码:R1196 / R1201
页数:6
相关论文
共 48 条
  • [31] Apoptosis by death factor
    Nagata, S
    [J]. CELL, 1997, 88 (03) : 355 - 365
  • [32] FAS AND FAS LIGAND - A DEATH FACTOR AND ITS RECEPTOR
    NAGATA, S
    [J]. ADVANCES IN IMMUNOLOGY, VOL 57, 1994, 57 : 129 - 144
  • [33] FAS-MEDIATED APOPTOSIS IN PRIMARY CULTURED MOUSE HEPATOCYTES
    NI, R
    TOMITA, Y
    MATSUDA, K
    ICHIHARA, A
    ISHIMURA, K
    OGASAWARA, J
    NAGATA, S
    [J]. EXPERIMENTAL CELL RESEARCH, 1994, 215 (02) : 332 - 337
  • [34] MICE LACKING THE TUMOR-NECROSIS-FACTOR RECEPTOR-1 ARE RESISTANT TO TNF-MEDIATED TOXICITY BUT HIGHLY SUSCEPTIBLE TO INFECTION BY LISTERIA-MONOCYTOGENES
    ROTHE, J
    LESSLAUER, W
    LOTSCHER, H
    LANG, Y
    KOEBEL, P
    KONTGEN, F
    ALTHAGE, A
    ZINKERNAGEL, R
    STEINMETZ, M
    BLUETHMANN, H
    [J]. NATURE, 1993, 364 (6440) : 798 - 802
  • [35] IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock
    Sakao, Y
    Takeda, K
    Tsutsui, H
    Kaisho, T
    Nomura, F
    Okamura, H
    Nakanishi, K
    Akira, S
    [J]. INTERNATIONAL IMMUNOLOGY, 1999, 11 (03) : 471 - 480
  • [36] Seino K, 1998, J IMMUNOL, V161, P4484
  • [37] Contribution of Fas ligand to T cell-mediated hepatic injury in mice
    Seino, KI
    Kayagaki, N
    Takeda, K
    Fukao, K
    Okumura, K
    Yagita, H
    [J]. GASTROENTEROLOGY, 1997, 113 (04) : 1315 - 1322
  • [38] Resistance of CD7-deficient mice to lipopolysaccharide-induced shock syndromes
    Sempowski, GD
    Lee, DM
    Scearce, RM
    Patel, DD
    Haynes, BF
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06) : 1011 - 1016
  • [39] Pharmacokinetics, immunogenicity, and efficacy of dimeric TNFR binding proteins in healthy and bacteremic baboon
    Solorzano, CC
    Kaibara, A
    Hess, PJ
    Edwards, PD
    Ksontini, R
    Abouhamze, A
    McDaniel, S
    Frazier, J
    Trujillo, D
    Kieft, G
    Seely, J
    Kohno, T
    Cosenza, ME
    Clare-Salzler, M
    MacKay, SLD
    Martin, SW
    Moldawer, LL
    Edwards, CK
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1998, 84 (04) : 1119 - 1130
  • [40] A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality
    Solorzano, CC
    Ksontini, R
    Pruitt, JH
    Auffenberg, T
    Tannahill, C
    Galardy, RE
    Schultz, GP
    MacKay, SLD
    Copeland, EM
    Moldawer, LL
    [J]. SHOCK, 1997, 7 (06): : 427 - 431